| Identification | Back Directory | [Name]
Imidazo[1,5,4-de][1,4]benzoxazin-2(1H)-one, 7-(3,5-dimethyl-4-isoxazolyl)-4,5-dihydro-4-(2-pyridinyl)-, (4R)- | [CAS]
1628607-63-5 | [Synonyms]
(R)-INCB054329
Imidazo[1,5,4-de][1,4]benzoxazin-2(1H)-one, 7-(3,5-dimethyl-4-isoxazolyl)-4,5-dihydro-4-(2-pyridinyl)-, (4R)- | [Molecular Formula]
C19H16N4O3 | [MOL File]
1628607-63-5.mol | [Molecular Weight]
348.36 |
| Hazard Information | Back Directory | [Uses]
(R)-INCB054329 is the isomer of INCB054329 (HY-112504), and can be used as an experimental control. INCB054329 is a potent BET inhibitor. | [References]
[1] Pérez-Salvia M, et al. Bromodomain inhibitors and cancer therapy: From structures to applications. Epigenetics. 2017 May 4;12(5):323-339. DOI:10.1080/15592294.2016.1265710
[2] Phillip CC Liu, et al. Abstract 3523: Discovery of a novel BET inhibitor INCB054329. |
|
|